JPMorgans Summer Reading List for Wealthy Clients Highlights AI Leadership and Resilience
Chinese Vape Makers Face Regulatory Headwinds in Dominant German Market
US Consumer Prices Rise 38 Annually in April Surpassing Forecasts
Financial Services Roundup Market Talks Highlight Experian SoFi Technologies and Sector Developments
Asian Markets Track Wall Streets Record Highs Oil Prices Retreat
Kevin Warsh Poised to Enter Fed Amid Internal Debate Over Interest Rate Cuts
Imperial Petroleum Inc 875 Series A Cumulative Redeemable Perpetual Preferred Shares IMPPP Q1 2026 Earnings Preferred EPS Surges Past Estimates on 67 Beat
Heritage Insurance Holdings Inc HRTG Q1 2026 Earnings EPS Misses Estimates Amid Challenging Underwriting Environment
CheckCap Ltd MBAI Q3 2023 Earnings EPS Misses Estimates as PreRevenue Company Continues RD Efforts
BWLP Q4 2025 Earnings EPS Surpasses Estimates by 458 as Stock Declines
UL Solutions Q1 2026 Earnings EPS Surges Past Estimates with 20 Beat
Helix Energy Solutions Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher
Bayview Acquisition Corp BAYA Surges 209 as SPAC Gains Momentum
Nuveen AMTFree Municipal Credit Income Fund NVG Inches Up 049 Approaches Key Resistance
Via Renewables Preferred Stock VIASP Holds Steady Near 256 Amid Narrow Trading Range
Oxford Lane Capital Corp 875 Notes 2030 OXLCI Modest Gain Amid Stable Yield Positioning
Oyster Enterprises II Acquisition Corp Units OYSEU Holds Steady at 1031 as SPAC Units Trade in Narrow Range
Alibaba Advances AI Ambitions with Enhanced Zhenwu Chip and New Large Language Model
RNXT Q1 2026 Earnings EPS Misses Estimates as Company Advances Pipeline
Waters Corporation WAT Surges 716 Momentum Builds Toward Key Resistance
JBL Q1 2026 Earnings EPS Surge Beats Estimates Shares Rally 44
CALY Q1 2026 Earnings EPS Surges 288 Above Estimates Stock Dips 315
MiNK Therapeutics Q1 2026 Earnings Narrowed Loss Exceeds Expectations Amid Clinical Progress
NEXN Q3 2025 Earnings Strong EPS Beat Drives Positive Stock Reaction
CTNM Q1 2026 Earnings Narrower Loss Beats Estimates as PreRevenue Biotech Maintains Discipline
BURU Q3 2023 Earnings PreRevenue Loss of 014 per Share as Strategic Developments Underway
PRDO Q1 2026 Earnings EPS Surpasses Estimates by 5 Stock Declines Slightly